What to expect from Aethlon Medical Inc’s (AEMD) current quarter earnings?

Currently, Aethlon Medical Inc’s (AEMD) stock is trading at $1.28, marking a fall of -34.00% from last night’s close. At this price, the stock is -84.83% below its 52-week high of $8.44 and -8.54% above its 52-week low of $1.40. Based on the past 30-day period, the stock price is -59.49% below the high and +6.67% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, AEMD’s SMA-200 is $3.5505.

AEMD’s price to book ratio for the most recent quarter was 0.52, resulting in an 0.53 price to cash per share for the period.

How does Aethlon Medical Inc (AEMD) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.

Aethlon Medical Inc (AEMD): Earnings History

If we examine Aethlon Medical Inc’s recent earnings history, in the last quarter ended on 3/31/2025, it posted adjusted earnings per share of -$3.7, beating the consensus of -$1.09. In other words, it beat the consensus by -$2.61, resulting in a -239.45% surprise. In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$3.7 in contrast with the Outlook of -$1.09. That was a difference of -$2.61 and a surprise of -239.45%.

Aethlon Medical Inc (NASDAQ: AEMD) Ownership Details

I will give a breakdown of the key shareholders in Aethlon Medical Inc (AEMD). Recent figures show that the company’s insiders hold 4.51% of shares. A total of 22 institutional investors hold shares in the company, making 21.03% of its stock and 22.03% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Armistice Capital, LLC holding total of 178.49 shares that make 8.88% of the company’s total number of shares and are currently priced at 0.23 million.

The securities firm Ikarian Capital, LLC holds 153.66 shares of AEMD, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 7.64% , and the holding percentage of shares is valued at 0.2 million.

An overview of Aethlon Medical Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Aethlon Medical Inc (AEMD) traded 241,347 shares per day, with a moving average of $2.0836 and price change of -1.7120. With the moving average of $2.6794 and a price change of -1.5264, about 107,176 shares changed hands on average over the past 50 days. Finally, AEMD’s 100-day average volume is 69,373 shares, alongside a moving average of $3.2689 and a price change of -4.0648.

Hot this week

Can you still get a good price for NeuroPace Inc (NPCE) Shares at this point?

While NeuroPace Inc has overperformed by 0.44%, investors are...

A stock that deserves closer examination: Opus Genetics Inc (IRD)

While Opus Genetics Inc has overperformed by 2.52%, investors...

Results from Duos Technologies Group Inc (DUOT) show risk

While Duos Technologies Group Inc has underperformed by -0.78%,...

Was anything negative for Nkarta Inc (NKTX) stock last session?

While Nkarta Inc has underperformed by -3.64%, investors are...

Farmer Bros. Co FARM’s stock price falss traction on Friday

While Farmer Bros. Co has underperformed by -0.50%, investors...

Topics

Can you still get a good price for NeuroPace Inc (NPCE) Shares at this point?

While NeuroPace Inc has overperformed by 0.44%, investors are...

A stock that deserves closer examination: Opus Genetics Inc (IRD)

While Opus Genetics Inc has overperformed by 2.52%, investors...

Results from Duos Technologies Group Inc (DUOT) show risk

While Duos Technologies Group Inc has underperformed by -0.78%,...

Was anything negative for Nkarta Inc (NKTX) stock last session?

While Nkarta Inc has underperformed by -3.64%, investors are...

Farmer Bros. Co FARM’s stock price falss traction on Friday

While Farmer Bros. Co has underperformed by -0.50%, investors...

VEON Ltd ADR (VEON)’s stock chart: A technical perspective

While VEON Ltd ADR has underperformed by -3.56%, investors...

AudioEye Inc (AEYE)’s stock performance: a year in review

While AudioEye Inc has overperformed by 3.13%, investors are...

Qudian Inc ADR (QD)’s stock price in review: A technical analysis

While Qudian Inc ADR has underperformed by -0.44%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.